Glenmark shares in focus after recall of 15 lakh bottles of ADHD drug in US
Glenmark share price: The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark Pharmaceuticals Inc., USA, a subsidiary of the Mumbai-based pharmaceutical company.
https://economictimes.indiatimes.com/markets/stocks/news/glenmark-shares-in-focus-after-recall-of-15-lakh-bottles-of-adhd-drug-in-us/articleshow/118673203.cms
Published At: Monday, March 03, 2025 03:55:00 AM UTC
#ADHDdrug #lakhbottles #bottlesofADHD #bitcoin
/ BTC News
npub1eh…5rsjv
2025-03-04 05:17:37
Author Public Key
npub1ehuz48h9qqm9uchtrf6zkwr9679ygj24htxj6wh9ldn4tzt6yuws05rsjvPublished at
2025-03-04 05:17:37Event JSON
{
"id": "1516e0b198eab7a811d4dfac1eca200646e368e4d73e0bb186d3d549df7b28f5",
"pubkey": "cdf82a9ee500365e62eb1a742b3865d78a444955bacd2d3ae5fb6755897a271d",
"created_at": 1741065457,
"kind": 1,
"tags": [],
"content": "Glenmark shares in focus after recall of 15 lakh bottles of ADHD drug in US\n\nGlenmark share price: The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark Pharmaceuticals Inc., USA, a subsidiary of the Mumbai-based pharmaceutical company.\n\nhttps://economictimes.indiatimes.com/markets/stocks/news/glenmark-shares-in-focus-after-recall-of-15-lakh-bottles-of-adhd-drug-in-us/articleshow/118673203.cms\n\nPublished At: Monday, March 03, 2025 03:55:00 AM UTC\n\n#ADHDdrug #lakhbottles #bottlesofADHD #bitcoin",
"sig": "7892d9ccee3bf2e7de529f7c6d5b412c7e074cbf77054a4d23d176586adfc1358bbb8195051f1c80cca07b7015cc3a6e68db3c029e486a86d2274a68e2d00ed6"
}